- Favorable safety profile of ixekizumab: results from 11 moderate-to-s…
Number of the records: 1  

Favorable safety profile of ixekizumab: results from 11 moderate-to-severe psoriasis and 3 psoriatic arthritis clinical trials

  1. Favorable safety profile of ixekizumab: results from 11 moderate-to-severe psoriasis and 3 psoriatic arthritis clinical trials / Gottlieb A. ... [et al.]. Dermatológia pre prax Roč. 12, č. 3 (2018), s. 147
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.

Accept allSettingsReject all